Cathy Begley-Frawley currently serves as the Disease Area Executive Vice President at Vertex Pharmaceuticals since January 2024. Prior to this role, Cathy held numerous leadership positions at Pfizer from 1999 to September 2025, including Vice President of Commercial Strategy and Innovation, Vice President of Commercial Development, and Senior Director of Marketing. Throughout Cathy's career at Pfizer, significant contributions included championing Inflammation & Immunology, leading commercial development initiatives in Emerging Markets, and managing market strategies for various therapeutic areas. Cathy began the journey in marketing at Pfizer, progressing through increasingly responsible roles. Educational credentials include a degree from Trinity College Dublin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices